Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy

JACC Cardiovasc Imaging. 2014 Nov;7(11):1175-7. doi: 10.1016/j.jcmg.2014.04.024. Epub 2014 Nov 10.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiretroviral Therapy, Highly Active* / adverse effects
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / etiology*
  • Cardiomyopathies / metabolism
  • Case-Control Studies
  • HIV Infections / complications
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV-Associated Lipodystrophy Syndrome / diagnosis
  • HIV-Associated Lipodystrophy Syndrome / etiology*
  • HIV-Associated Lipodystrophy Syndrome / metabolism
  • Humans
  • Magnetic Resonance Imaging
  • Magnetic Resonance Spectroscopy
  • Myocardial Contraction
  • Myocardium / chemistry
  • Predictive Value of Tests
  • Risk Factors
  • Treatment Outcome
  • Triglycerides / analysis
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / etiology*
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Function, Left*

Substances

  • Triglycerides